Boston Medical Sciences

Tokyo, Japan · Founded 2023 · Privately Held (backing)

Developer of a non-invasive colorectal cancer detection platform designed to improve patient outcomes by leveraging data for decision-making. Boston Medical Sciences is based in Tokyo, Japan and was founded in 2023. Its last known valuation is $31 million. It has raised $9.2 million.

Last price · $/share
—
Implied valuation
$31.0M
Total raised
$9.2M
Last round
—
What is Boston Medical Sciences worth?
$31.0Mlast known valuation
Free account
More of Boston Medical Sciences with a free account
  • ·Watch Boston Medical Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Boston Medical Sciences funding history

No rounds on record

No funding rounds for Boston Medical Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Boston Medical Sciences valuation

Boston Medical Sciences's last known valuation is $31 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Boston Medical Sciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Boston Medical Sciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Boston Medical Sciences

What is Boston Medical Sciences worth?
Boston Medical Sciences's last known valuation is $31.0M.
How much has Boston Medical Sciences raised?
Boston Medical Sciences has raised $9.2M in total funding across its recorded rounds.